The structure and function of the glucagon-like peptide-1 receptor and its ligands

被引:211
|
作者
Donnelly, Dan [1 ]
机构
[1] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England
关键词
GLP-1; GPCR; exendin-4; exenatide; liraglutide; diabetes; glucagon; insulin; VASOACTIVE-INTESTINAL-PEPTIDE; GUINEA-PIG PANCREAS; N-TERMINAL DOMAIN; GLP-1; 7-36; AMIDE; IN-VITRO; INSULIN-SECRETION; DISPERSED ACINI; EXTRACELLULAR DOMAIN; PARATHYROID-HORMONE; BIOLOGICAL-ACTIVITY;
D O I
10.1111/j.1476-5381.2011.01687.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-residue peptide hormone released from intestinal L cells following nutrient consumption. It potentiates the glucose-induced secretion of insulin from pancreatic beta cells, increases insulin expression, inhibits beta-cell apoptosis, promotes beta-cell neogenesis, reduces glucagon secretion, delays gastric emptying, promotes satiety and increases peripheral glucose disposal. These multiple effects have generated a great deal of interest in the discovery of long-lasting agonists of the GLP-1 receptor (GLP-1R) in order to treat type 2 diabetes. This review article summarizes the literature regarding the discovery of GLP-1 and its physiological functions. The structure, function and sequenceactivity relationships of the hormone and its natural analogue exendin-4 (Ex4) are reviewed in detail. The current knowledge of the structure of GLP-1R, a Family B GPCR, is summarized and discussed, before its known interactions with the principle peptide ligands are described and summarized. Finally, progress in discovering non-peptide ligands of GLP-1R is reviewed. GLP-1 is clearly an important hormone linking nutrient consumption with blood sugar control, and therefore knowledge of its structure, function and mechanism of action is of great importance.
引用
收藏
页码:27 / 41
页数:15
相关论文
共 50 条
  • [1] Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
    Underwood, Christina Rye
    Garibay, Patrick
    Knudsen, Lotte Bjerre
    Hastrup, Sven
    Peters, Gunther H.
    Rudolph, Rainer
    Reedtz-Runge, Steffen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (01) : 723 - 730
  • [2] Impact of glucagon-like peptide-1 on endothelial function
    Sjoholm, A.
    DIABETES OBESITY & METABOLISM, 2009, 11 : 19 - 25
  • [3] Actions of glucagon-like peptide-1 receptor ligands in the gut
    Holst, Jens Juul
    Andersen, Daniel Bjorklund
    Grunddal, Kaare Villum
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 727 - 742
  • [4] The Glucagon-Like Peptide-1 Receptor-or Not?
    Pyke, Charles
    Knudsen, Lotte Bjerre
    ENDOCRINOLOGY, 2013, 154 (01) : 4 - 8
  • [5] Glucagon-like peptide-1 receptor agonist use in pregnancy: a review
    Drummond, Rosa F.
    Seif, Karl E.
    Reece, Albert
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2025, 232 (01) : 17 - 25
  • [6] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [7] Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
    Willard, Francis S.
    Sloop, Kyle W.
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [8] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [9] Effects of glucagon-like peptide-1 receptor agonists on renal function
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    WORLD JOURNAL OF DIABETES, 2013, 4 (05) : 190 - 201
  • [10] Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure
    Yoon, Gwangho
    Kim, Young-Kook
    Song, Juhyun
    PHARMACOLOGICAL RESEARCH, 2020, 152